ACR# [002]

Related by string. ACR# [001] * * ACR# response . achieved ACR# . ACR# responses . ACR# ACR# *

Related by context. Frequent words. (Click for all words.) 60 placebo p = 60 sustained virologic response 60 secondary endpoint 59 adalimumab 59 etanercept 58 placebo p 58 primary efficacy endpoint 58 mg BID 57 primary endpoint 57 evaluable 57 ACTEMRA 57 clinical endpoints 57 free survival PFS 57 peginterferon alfa 2a 56 Secondary endpoints 56 undetectable viral load 56 mg dose 56 clinically meaningful 56 median PFS 56 lacosamide 55 Secondary endpoints included 55 certolizumab pegol 55 nonresponders 55 demonstrated statistically significant 55 LVEF 55 copies mL 55 HbA1c levels 55 secondary endpoints 55 RECIST criteria 55 evaluable patients 54 p = #.# [002] 54 infliximab 54 symptom severity 54 HbA1c 54 p = #.# [004] 54 peginterferon 54 IU mL 54 P = .# 54 placebo 54 metastatic renal cell carcinoma 53 monotherapy 53 tiotropium 53 RECIST 53 Secondary endpoints include 53 chronic angina 53 primary endpoints 53 FOLFOX 53 belimumab 53 fasting plasma glucose 52 mcg kg 52 Torisel 52 composite endpoint 52 Welchol 52 pharmacodynamic 52 plus ribavirin 52 allopurinol 52 log# 52 dasatinib 52 glimepiride 52 XGEVA 52 statistically significant p 51 TIMI 51 mg doses 51 pramipexole 51 PASI 51 creatinine clearance 51 preoperatively 51 SEROQUEL 51 microalbuminuria 51 abatacept 51 tumor shrinkage 51 citalopram 51 histologic 51 pregabalin 51 bortezomib 51 statistical significance 51 topotecan 51 elagolix 51 azacitidine 51 confidence interval CI 51 nonsignificant 51 non inferiority 51 QoL 51 mg d 50 acute ischemic stroke 50 Cimzia ® 50 dyspnea 50 platelet aggregation 50 bosentan 50 telbivudine 50 Median survival 50 statistically significant improvement 50 ejection fraction 50 EULAR 50 statistically significant reduction 50 rotigotine 50 hypercalcemia 50 dimebon 50 sinus rhythm 50 A1C levels 50 fluticasone

Back to home page